WT

Wu Zhen Tao

Mr. Wu is the Non-Executive Chairman and is the Chairman of the Remuneration Committee of the Company and founder of the Group, which has over 20 years’ history of business and investment focused in the PRC. He was born and educated in Beijing and is a graduate of Beijing Industrial University. He also has a degree in Business Administration. Following a period as a senior executive in government scientific institutes, he held posts as managing director of two newly established state owned financial institutions. Since 1988 Mr. Wu has, through companies, invested in and developed the Landmark Hotel (now called Crowne Plaza Hotel & Suites Landmark Shenzhen) in Shenzhen and established the Cathay International Water Limited group of companies, which made substantial investments in public utility and infrastructure in the PRC. Strategic shareholders were JP Morgan, Singapore Technologies, UBS, Banco Santander and Nomura JAFCO, and this business was once the largest foreign investor in water and waste water treatment projects in the PRC with net assets of over USD1 billion. Since 30 March 2017, Mr. Wu has been the Chairman of the Board and Chairman of the Executive Committee of the Company’s subsidiary, Lansen Pharmaceutical Holdings Limited, which is listed on the Hong Kong Stock Exchange.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


C

Cathay International Holdings Ltd

CATHAY INTERNATIONAL HOLDINGS LIMITED is an investment holding company principally engaged in the healthcare business. The Company operates five business segments through its subsidiaries. The Lansen segment engages in the manufacture and sale of pharmaceuticals, cosmeceutical products and plant extracts and healthcare products. The Haizi segment produces inositol and its by-product, di-calcium phosphate. The Natural Dailyhealth segment is involved in the production and sales of plant extracts for use as active ingredients in health products. The Botai segment involves in the production and sales of collagen injectable fillers and development of collagen related products. The Hotel Operation segment operates a hotel.


Industries

Employees

1,001-5,000

Links